This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.
February 24, 2021
m 11:46 | Neuroblastoma (diff | hist) . . (+14) . . Tony.Ching.AAO (Talk | contribs) (→minor formatting) |
February 23, 2021
19:09 | (Move log) . . [Tony.Ching.AAO (4×)] | |
19:09 . . Tony.Ching.AAO (Talk | contribs) moved page Canalicular obstruction to Canalicular Obstruction (title standardization) | ||
18:52 . . Tony.Ching.AAO (Talk | contribs) moved page Canalicular laceration (trauma) to Canalicular Laceration (Trauma) (title standardization) | ||
18:17 . . Tony.Ching.AAO (Talk | contribs) moved page Bloody tears to Bloody Tears (title standardization) | ||
18:15 . . Tony.Ching.AAO (Talk | contribs) moved page Blepharophimosis syndrome to Blepharophimosis Syndrome (title standardization) |
01:03 | Teprotumumab (3 changes | history) . . (+136) . . [Lalita.Gupta (3×)] | |
m | 01:03 (cur | prev) . . (+2) . . Lalita.Gupta (Talk | contribs) (→Overview) (Tag: VisualEditor) | |
m | 00:54 (cur | prev) . . (+127) . . Lalita.Gupta (Talk | contribs) | |
00:15 (cur | prev) . . (+7) . . Lalita.Gupta (Talk | contribs) |
February 22, 2021
February 21, 2021
N 20:05 | Teprotumumab (26 changes | history) . . (+19,870) . . [Lalita.Gupta (26×)] | |
20:05 (cur | prev) . . (-4) . . Lalita.Gupta (Talk | contribs) (→Pharmacokinetics) (Tag: VisualEditor) | ||
19:55 (cur | prev) . . (+9) . . Lalita.Gupta (Talk | contribs) (→Safety) | ||
19:34 (cur | prev) . . (+9) . . Lalita.Gupta (Talk | contribs) | ||
19:09 (cur | prev) . . (+6) . . Lalita.Gupta (Talk | contribs) (→Safety) (Tag: VisualEditor) | ||
19:08 (cur | prev) . . (+13) . . Lalita.Gupta (Talk | contribs) (→Safety) (Tag: VisualEditor) | ||
19:07 (cur | prev) . . (+7) . . Lalita.Gupta (Talk | contribs) (→Safety) | ||
19:04 (cur | prev) . . (+46) . . Lalita.Gupta (Talk | contribs) (→Safety) | ||
18:54 (cur | prev) . . (+14) . . Lalita.Gupta (Talk | contribs) (→Safety: table) (Tag: VisualEditor) | ||
18:52 (cur | prev) . . (+760) . . Lalita.Gupta (Talk | contribs) (→Safety) (Tag: VisualEditor) | ||
18:46 (cur | prev) . . (+8) . . Lalita.Gupta (Talk | contribs) | ||
18:45 (cur | prev) . . (-8) . . Lalita.Gupta (Talk | contribs) | ||
18:43 (cur | prev) . . (-11) . . Lalita.Gupta (Talk | contribs) (→Mechanism of Action) | ||
18:41 (cur | prev) . . (+42) . . Lalita.Gupta (Talk | contribs) (→Overview) (Tag: VisualEditor) | ||
18:38 (cur | prev) . . (+102) . . Lalita.Gupta (Talk | contribs) | ||
18:26 (cur | prev) . . (+23) . . Lalita.Gupta (Talk | contribs) | ||
18:22 (cur | prev) . . (+328) . . Lalita.Gupta (Talk | contribs) (→Safety) | ||
18:20 (cur | prev) . . (+1) . . Lalita.Gupta (Talk | contribs) (→Indications) | ||
18:19 (cur | prev) . . (-3) . . Lalita.Gupta (Talk | contribs) (→Indications) | ||
18:19 (cur | prev) . . (+446) . . Lalita.Gupta (Talk | contribs) (→Indications) | ||
18:16 (cur | prev) . . (+528) . . Lalita.Gupta (Talk | contribs) (→Clinical trials) | ||
18:13 (cur | prev) . . (+18) . . Lalita.Gupta (Talk | contribs) (→Dosing and Administration) | ||
18:12 (cur | prev) . . (-12) . . Lalita.Gupta (Talk | contribs) (→References) | ||
18:11 (cur | prev) . . (+240) . . Lalita.Gupta (Talk | contribs) (→Pharmacokinetics) | ||
18:09 (cur | prev) . . (+1,911) . . Lalita.Gupta (Talk | contribs) (→Mechanism of Action) | ||
18:02 (cur | prev) . . (+3,512) . . Lalita.Gupta (Talk | contribs) (Tag: VisualEditor: Switched) | ||
N | 17:33 (cur | prev) . . (+11,885) . . Lalita.Gupta (Talk | contribs) (Created page with "{{Article |Authors=Lalita Gupta,Mark Prendes,Raymond Douglas |Category=Oculoplastics/Orbit |Date reviewed=February 21, 2021 |Meta description=Teprotumumab is a fully human mon...") |